#TransthyretinAmyloidosis
LightNews LightNews
sinaigenhealth.bsky.social
📄 “A Phenotype Risk Score–Triggered E-Visit Pathway to Capture TTR V142I in a Heart Failure Population”

🔗 Read the study in JACC: Case Reports
www.jacc.org/doi/10.1016/...

#Genomics #CardiovascularGenetics #GenomicMedicine #EHR #PrecisionMedicine #TransthyretinAmyloidosis
A Phenotype Risk Score–Triggered E-Visit Pathway to Capture <i>TTR</i> V142I in a Heart Failure Population:
How to cite this article: Johnson, J, Sarkar, D, Kornblau, I. et al. A Phenotype Risk Score–Triggered E-Visit Pathway to Capture TTR V142I in a Heart Failure Population. J Am Coll Cardiol Case Rep.…
www.jacc.org
September 29, 2026 at 10:01 PM
rarediseaseadvisor.bsky.social
Precise evaluation with routine cardiac diagnosis can help identify patients with wild-type transthyretin amyloidosis (#ATTR) who have a high risk of mortality.

Read here: https://bit.ly/3XlAWGH

#RareDisease #TransthyretinAmyloidosis #Cardiology
QRS Duration May Be a Marker for Survival in Wild-Type ATTR
Precise evaluation with routine cardiac diagnosis can help identify patients with wild-type ATTR who have a high risk of mortality.
bit.ly
November 11, 2025 at 6:11 PM
jamacardiology.com
Among patients with #TransthyretinAmyloidosis with cardiomyopathy, impaired left atrial strain on #Echocardiography was associated with higher risk of death, cardiovascular events, heart failure hospitalization, and atrial fibrillation.

ja.ma/4gpsqji
Forest plot showing HR (95% CI) for Left Atrial Strain (LAS), LA Volume Index (LAVI), and A-Wave Velocity versus Clinical Outcomes. Multiple outcomes (CV events, death, HF hospitalizations, AF/AFI) are listed. Many LAS and A-wave velocity metrics show increased risk (HR>1) for adverse outcomes.
August 19, 2026 at 6:56 PM